SCHEMBL7700583

SCHEMBL7700583

N#Cc1cccc(C(=O)CC(=O)Nc2cc(-c3ccccc3)c(Cl)cc2NC(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.43
BRAF P15056 2/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 3/20 0.41
GRM5 P41594 2/20 0.39
HDAC3 O15379 1/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
TRPM4 Q8TD43 1/20 0.39
VNN1 O95497 1/20 0.39
GPR139 Q6DWJ6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141324 0.87 MEN1 (0.38) GSK3BBRAFALDH1A1MAPTMAPK1
SCHEMBL6609458 0.82 GSK3B (0.43) GSK3BALDH1A1MAPTMAPK1MEN1
SCHEMBL7459390 0.80 GSK3B (0.46) GSK3BKMT2ARAB9AGRM5HDAC3
SCHEMBL7459196 0.77 MAPK14 (0.48) GSK3BALDH1A1RAB9AGRM5NPC1
SCHEMBL7704530 0.76 DHODH (0.37) GSK3BALDH1A1MEN1KMT2ARAB9A
SCHEMBL7463263 0.76 GPR139 (0.45) GSK3BALDH1A1KMT2ARAB9AGRM5
SCHEMBL7465211 0.75 GSK3B (0.40) GSK3BALDH1A1RAB9AGRM5HDAC3
SCHEMBL7467152 0.75 ERCC5 (0.50) GSK3BALDH1A1MEN1KMT2ARAB9A
SCHEMBL7065166 0.75 VCP (0.45) GSK3BRAB9AGRM5HDAC3LMNA
SCHEMBL7703990 0.75 GSK3B (0.41) GSK3BMAPK1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed